Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Terlipressin
Drug ID BADD_D02167
Description Terlipressin is an analogue of vasopressin used as a vasoactive drug in the management of hypotension which has been found to be effective when norepinephrine fails.
Indications and Usage Commonly used to stop bleeding of varices in the food pipe (oesophagus).
Marketing Status Not Available
ATC Code H01BA04
DrugBank ID DB02638
KEGG ID D06672
MeSH ID D000077585
PubChem ID 72081
TTD Drug ID D0P4VX
NDC Product Code 41701-016; 41701-009
Synonyms Terlipressin | Glycylpressin | TGLVP | Terlypressin | Triglycyl Lysine Vasopressin | Triglycylvasopressin | Glipressin | Glypressin | Triglycyl-(8-lysine)vasopressin | Gly-Gly-Gly-8-Lys-vasopressin | Gly Gly Gly 8 Lys vasopressin | N-(alpha)-glycyl-glycyl-glycyl-8-lysine vasopressin | Vasopressin, tri-Gly-8-Lys- | tri-Gly-8-Lys- Vasopressin | Remestyp
Chemical Information
Molecular Formula C52H74N16O15S2
CAS Registry Number 14636-12-5
SMILES C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N) CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)NC(CCCCN)C(=O)NCC(=O)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Atrial fibrillation02.03.03.002--
Blood creatinine decreased13.13.01.003--Not Available
Bradycardia02.03.02.002--Not Available
Cardiac failure02.05.01.001--
Chest pain08.01.08.002; 02.02.02.011; 22.02.08.003--Not Available
Cyanosis24.03.01.007; 22.02.02.007; 02.01.02.002--
Diarrhoea07.02.01.001--
Dyspnoea22.02.01.004; 02.01.03.002--
Fluid overload02.05.04.004; 14.05.06.001--Not Available
Gastrointestinal disorder07.11.01.001--Not Available
Headache17.14.01.001--
Hypertension24.08.02.001--
Hyponatraemia14.05.04.002--
Injection site necrosis12.07.03.020; 08.02.03.020--Not Available
Intestinal ischaemia07.15.02.001; 24.04.08.001--Not Available
Menopausal symptoms21.02.02.002--Not Available
Mesenteric vascular insufficiency24.04.08.011; 07.15.02.010--Not Available
Myocardial infarction24.04.04.009; 02.02.02.007--
Nausea07.01.07.001--
Nervous system disorder17.02.10.001--Not Available
Pallor23.03.03.031; 08.01.03.032; 24.03.04.001--Not Available
Peripheral ischaemia24.04.03.002--
Pregnancy18.08.02.004--Not Available
Pulmonary oedema22.01.03.003; 02.05.02.003--
Respiratory distress22.02.01.012--Not Available
Respiratory failure22.02.06.002; 14.01.04.003--
Skin disorder23.03.03.007--Not Available
Skin exfoliation23.03.07.003--Not Available
Skin necrosis23.03.03.011--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages